FN1 and Hepatic fibrosis: To determine whether FN-EDA promoted angiogenesis in hepatic fibrosis, we produced FN-EDA knockdown mice through tail vein injection using a recombinant EDA-AAV9 vector and then treated the mice with CCl4 for 8 weeks.